Results of general meeting Mediclinic International Limited Incorporated in the Republic of South Africa Reg. no. 1983/010725/06 Income tax no: 9950122714 JSE Share code: MDC NSX share code: MCI ISIN code: ZAE000074142 (“Mediclinic” or “the Company”) RESULTS OF GENERAL MEETING Shareholders are advised that at a general meeting of Mediclinic held today, 11 August 2015, all the ordinary and special resolutions proposed at the meeting were approved by the requisite majority of votes, as set out below. Resolutions Votes exercised (as a Total number Shares voted Shares percentage of the total of shares (as a abstained (as a number of shares voted) voted percentage of percentage of For Against the total issued the total issued share capital) share capital) ORDINARY RESOLUTIONS: 1. Specific Authority to issue 100.00% 0.00% 723 338 792 83.34% 0.09% shares for cash to Mpilo 1 Newco 2. Authority for directors or 100.00% 0.00% 723 338 710 83.34% 0.09% company secretary to sign and act SPECIAL RESOLUTIONS: 1. Specific authority to 100.00% 0.00% 723 338 803 83.34% 0.09% repurchase shares from Mpilo 1 2. Specific authority to 100.00% 0.00% 723 338 710 83.34% 0.09% provide financial assistance to Mpilo 1 Stellenbosch 11 August 2015 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 (if dialling from South Africa) or ethics@mediclinic.com Website: www.mediclinic.com Financial advisor and JSE sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor Simonis Storm Securities (Proprietary) Limited Legal advisor Cliffe Dekker Hofmeyr Inc. Corporate advisor to the Mpilo 1 empowerment consortium Leaf Capital Proprietary Limited Date: 11/08/2015 03:41:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.